▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #331 by analyst upside · 2026-06-27
DH
Definitive Healthcare Corp.
Healthcare · Market Cap $70M · P/E 0x
ANALYST PRICE TARGET
+304.0%
implied upside to consensus target
Current Price $0.66
Consensus Target $2.67
Bull Target $3.5
Bear Target $1.0
Analysts Covering 6
ANALYST CONSENSUS — HOLD
Strong Buy
0
Buy
2
Hold
4
Sell
0
52-Week Low $0.62
52-Week High $4.7
YTD Return -72.2%
FUNDAMENTALS
Market Cap $70M
P/E Ratio (TTM) N/A
Forward P/E 3.5x
EPS (TTM) $-1.67
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $238M
Profit Margin -71.5%
52-WEEK RANGE
52-Week Low $0.62
52-Week High $4.7
Current Price $0.66
Bear Target $1.0
Bull Target $3.5
● Now $0.66 ● Target $2.67
TRADING DATA
Avg Volume 300K
YTD Return -72.2%
Analyst Count 6
Consensus Hold
Upside to Target +304.0%
Last Updated 2026-06-27

ANALYST SUMMARY

Definitive Healthcare Corp. (DH) is currently trading at $0.66 with a Wall Street consensus price target of $2.67, implying potential upside of 304.0% over the next 12 months. 6 analysts currently cover DH, with a consensus rating of Hold — 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.5, while the most cautious has a target of $1.0.

DH operates in the Healthcare sector with a market capitalisation of $70M. The stock is down 72.2% year-to-date and is currently trading near the lower end of its 52-week range of $0.62 – $4.7.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

FBIO +298.6%
Fortress Biotech, Inc.
$92M · P/E 0.9x · Buy
XTNT +193.6%
Xtant Medical Holdings, Inc.
$59M · P/E 42.0x · Buy
PLX +378.3%
Protalix BioTherapeutics, Inc.
$185M · P/E 12.1x · Buy
AGEN +411.6%
Agenus Inc.
$126M · P/E 1.4x · Buy
CCLD +184.9%
CareCloud, Inc.
$91M · P/E 16.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for DH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Underweight → Underweight 2026-03-30 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2026-02-27 Building track record
Stephens & Co. — Reiterated
Equal-Weight → Equal-Weight 2026-02-27 Building track record
Barclays — Reiterated
Underweight → Underweight 2025-12-09 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2025-11-10 Building track record
Stifel — Reiterated
Buy → Buy 2025-08-08 Building track record
Goldman Sachs — Reiterated
Neutral → Neutral 2025-05-12 Building track record
Goldman Sachs — Reiterated
Neutral → Neutral 2025-03-04 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →